ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,702.55
      -0.19%
      US Tech 100
      19,300.00
      0.01%
      Dow Jones
      42,063.36
      0.09%
      Brent Oil
      73.935
      0.07%
      Bitcoin
      63,680.17
      0.09%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Evofem Biosciences Inc (EVFM) Quote

      Evofem Biosciences Inc

      Evofem Biosciences Inc (EVFM)

      Evofem Biosciences Inc (QB)
      0.4782
      0.00
      (0.00%)
      Closed September 20 4:00PM
      Delayed by 15 minutes
      0.4782
      0.00
      ( 0.00% )
      Pre Market: 8:00PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      0.4782
      Bid
      0.465
      Ask
      0.468
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      2.716M
      Previous Close
      0.4782
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      5,680,000
      Dividend Yield
      -
      PE Ratio
      0.11
      Earnings Per Share (EPS)
      8.8
      Revenue
      18.22M
      Net Profit
      50M

      About Evofem Biosciences Inc

      Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmi... Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.evofem.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -

      Ask ADVFN Intelligence (AI)

      EVFM Latest News

      More News

      Biopharma Partners with Telemed Firm and Shares are Climbing

      This company is striving to change the narratives around women's healthcare and offering solutions that reinforce and improve them. And shares are responding positively to a recent partnership To...

      June 27 2024
      AllPennyStocks.com

      Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023

      Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023 PR Newswire SAN DIEGO, June 1, 2023 Increased net product revenue more than 35% in the first quarter of 2023...

      June 01 2023
      PR Newswire (US)

      Evofem Biosciences Announces 1-for-125 Reverse Stock Split

      Evofem Biosciences Announces 1-for-125 Reverse Stock Split PR Newswire SAN DIEGO, May 17, 2023 -- CUSIP number for Evofem will change to 30048L302 on May 18, 2023 -- -- Ticker symbol will change...

      May 17 2023
      PR Newswire (US)

      Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization Required

      Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization Required PR Newswire SAN DIEGO, April 12, 2023 — Improves Phexxi coverage for more than 5.8 million New York...

      April 12 2023
      PR Newswire (US)

      Evofem Biosciences Announces Cost Reduction Measures

      Evofem Biosciences Announces Cost Reduction Measures PR Newswire SAN DIEGO, March 21, 2023 – Company cuts management pay and lowers headcount to decrease operating costs – – Reductions align with...

      March 21 2023
      PR Newswire (US)

      Evofem Biosciences Appoints Interim Chief Financial Officer

      Evofem Biosciences Appoints Interim Chief Financial Officer PR Newswire SAN DIEGO, March 9, 2023 SAN DIEGO, March 9, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) is pleased to...

      March 09 2023
      PR Newswire (US)

      Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product Offering

      Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product Offering PR Newswire SAN DIEGO, Feb. 28, 2023 -- Phexxi is the first and only hormone-free contraceptive offered by reproductive...

      February 28 2023
      PR Newswire (US)

      Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for Phexxi

      Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for Phexxi PR Newswire SAN DIEGO, Feb. 27, 2023 -- Evofem now has four Orange Book listed patents covering...

      February 27 2023
      PR Newswire (US)

      Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value

      Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value PR Newswire SAN DIEGO, Feb. 23, 2023 SAN DIEGO, Feb. 23, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB:...

      February 23 2023
      PR Newswire (US)

      Costco Adds Phexxi® to Member Prescription Program

      Costco Adds Phexxi® to Member Prescription Program PR Newswire SAN DIEGO, Jan. 10, 2023 SAN DIEGO, Jan. 10, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) today announced that...

      January 10 2023
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NUKKNukkleus Inc
      $ 0.3679
      (73.13%)
      		11.24M
      SOXMTradr 2X Long SOXX Monthly ETF
      $ 36.96
      (58.98%)
      		31
      LGCBLinkage Global Inc
      $ 0.6357
      (51.97%)
      		6.42M
      LGHLWLion Group Holding Ltd
      $ 0.008
      (33.33%)
      		11
      SPPLSIMPPLE Ltd
      $ 0.48
      (31.51%)
      		1
      PRFXPainReform Ltd
      $ 0.6185
      (-19.79%)
      		13.85k
      SMXTSolarMax Technology Inc
      $ 0.7029
      (-19.75%)
      		200
      CJETChijet Motor Company Inc
      $ 2.28
      (-18.57%)
      		694
      ZJYLJin Medical International Ltd
      $ 3.33
      (-18.38%)
      		18.44k
      ADTXAditxt Inc
      $ 0.3152
      (-17.62%)
      		46.91k
      NUKKNukkleus Inc
      $ 0.3679
      (73.13%)
      		11.24M
      LGCBLinkage Global Inc
      $ 0.6357
      (51.97%)
      		6.42M
      GSIWGarden Stage Ltd
      $ 1.74
      (29.85%)
      		2.51M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.0787
      (-13.99%)
      		2.51M
      TGLTreasure Global Inc
      $ 0.8505
      (25.02%)
      		1.57M

      Discussion

      View Full Feed
      Hummingbird2 Hummingbird2 3 minutes ago
      https://x.com/ldev117/status/1836798460344848885

      $TAMG
      TAMG
      Rocket-Interceptor Rocket-Interceptor 7 minutes ago
      R/S Next year but not yet: https://www.nasdaq.com/market-activity/stock-splits
      Buying today some .08s (oversold here)
      MAXN
      urge2surge urge2surge 8 minutes ago
      Shares updated. No changes.

      https://www.otcmarkets.com/stock/IDVV/security
      IDVV
      JohnSmith4 JohnSmith4 9 minutes ago
      All you do is ask why why why. You have nothing to contribute.
      TSOI
      LVerstee LVerstee 9 minutes ago
      https://investorshub.advfn.com/uimage/uploads/2024/9/23/zzuxxmain-qimg-7c230a71bcc68950fafe3d665e5644ad.webp
      ITUP
      Zadie420 Zadie420 10 minutes ago
      That is true. They did it with DNDN. Oh man, they were wrong and stupid as usual with NWBO.
      NWBO
      easymoney easymoney 14 minutes ago
      All is great as I'm back in thailand after a month in Laos.
      LVerstee LVerstee 14 minutes ago
      I hate fiction. Let's stay with facts. The fact for instance that Laxmi is again delaying as much as he can. First writes a very long email outlining his empty promises, then goes silent again.

      https://investorshub.advfn.com/uimage/uploads/2024/9/23/ikmwgLaxmi_no_responses.png
      ITUP
      reena969 reena969 16 minutes ago
      NUKK RSI is at 17+, and it looks like the lower Bollinger Band support has been broken. We might see lower lows until around 6am
      NUKK
      TalShu TalShu 19 minutes ago
      Does the following remind Blue voters of a Sarissa proxy-war promise?

      Financial Times

      NHS lunches 'suscription' scheme for antibiotics with Pharma sector.

      Drugmakers will Receive flat fies for new medicines in push to avoide overuse.

      By Ian
      AMRN
      TIMGZ TIMGZ 22 minutes ago
      NO, NOT YET. AS U EXPRESSED***MIGHT BE 7AM RUN. I WANT TO SLEEP MORE
      reena969 reena969 22 minutes ago
      NUKK RSI, 28+ looking good 11.2 mil volume
      NUKK
      CarlCarlMcB CarlCarlMcB 23 minutes ago
      Merry Christmas $$$$$$)))
      AGRI
      Wayne R Wayne R 24 minutes ago
      When the forward split is implemented it would put the stock price a bit too close to the minimum $1.00 price threshold.

      The stock would need to rally otherwise a reverse split is inevitable.
      AGBA
      CarlCarlMcB CarlCarlMcB 24 minutes ago
      Harpoon!!!!!! Enjoy the ride $$$))))))))))
      AGRI
      reena969 reena969 25 minutes ago
      NUKK is approaching support with 10 million in volume, trading sideways—showing solid accumulation so far
      NUKK
      scotty3371 scotty3371 29 minutes ago
      Wow. Thanks flipper.
      NWBO
      Swammmie1040 Swammmie1040 29 minutes ago
      Its in the quarterly report approx $270,000 (outstanding balance)
      https://www.otcmarkets.com/otcapi/company/financial-report/409989/content
      Scroll down to convertable notes page 5 B
      SINC
      reena969 reena969 29 minutes ago
      LGCB just crossed under support , wait for second conformation candle
      Wayne R Wayne R 30 minutes ago
      Don't worry, it'll probably be delayed enough for Davie boyo to cash in his incentive shares.

      JMO
      MULN
      reena969 reena969 36 minutes ago
      TIMGZ are you back in NUKK?
      NUKK
      Investor2014 Investor2014 37 minutes ago
      See bits in bold.

      Given in the Blum and Huey complaint and then consolidated complaint are not doing a good job of:
      A PSLRA plaintiff must allege facts demonstrating the existence of the following elements to be entitled to discovery: “(1) a material misrepresentation (or omiss
      AVXL
      reena969 reena969 39 minutes ago
      LGCG RSI 70+
      reena969 reena969 41 minutes ago
      LGCG using middle Bollinger band as support, so far
      reena969 reena969 43 minutes ago
      NUKK .293 entry, 4.01:05
      .448 exit 4:02:15 Fast enough for you? $$$$$
      NUKK

      Your Recent History

      NASDAQ
      EVFM
      Evofem Biosciences
      Delayed Upgrade Clock